Westover Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.82M | Sell |
5,727
-166
| -3% | -$90.1K | 0.52% | 45 |
|
|
2025
Q4 | $3.41M | Sell |
5,893
-114
| -2% | -$64.5K | 0.62% | 38 |
|
|
2025
Q3 | $2.91M | Sell |
6,007
-58
| -1% | -$27K | 0.54% | 45 |
|
|
2025
Q2 | $2.46M | Sell |
6,065
-3,446
| -36% | -$1.44M | 0.49% | 49 |
|
|
2025
Q1 | $4.73M | Sell |
9,511
-186
| -2% | -$101K | 1.05% | 21 |
|
|
2024
Q4 | $5.04M | Sell |
9,697
-109
| -1% | -$59.9K | 1.11% | 20 |
|
|
2024
Q3 | $6.07M | Buy |
9,806
+912
| +10% | +$540K | 1.17% | 20 |
|
|
2024
Q2 | $4.92M | Sell |
8,894
-7
| -0.1% | -$4.01K | 1.27% | 19 |
|
|
2024
Q1 | $5.17M | Sell |
8,901
-204
| -2% | -$114K | 1.51% | 18 |
|
|
2023
Q4 | $4.83M | Sell |
9,105
-124
| -1% | -$60K | 1.57% | 16 |
|
|
2023
Q3 | $4.67M | Sell |
9,229
-431
| -4% | -$230K | 1.69% | 13 |
|
|
2023
Q2 | $5.04M | Sell |
9,660
-470
| -5% | -$254K | 1.75% | 11 |
|
|
2023
Q1 | $5.84M | Sell |
10,130
-15
| -0.1% | -$8.45K | 2.16% | 9 |
|
|
2022
Q4 | $5.59M | Sell |
10,145
-885
| -8% | -$469K | 2.21% | 8 |
|
|
2022
Q3 | $5.59M | Sell |
11,030
-100
| -0.9% | -$56K | 2.14% | 9 |
|
|
2022
Q2 | $6.05M | Sell |
11,130
-795
| -7% | -$438K | 2.23% | 9 |
|
|
2022
Q1 | $7.04M | Sell |
11,925
-444
| -4% | -$255K | 2.2% | 9 |
|
|
2021
Q4 | $8.25M | Sell |
12,369
-1,312
| -10% | -$819K | 2.4% | 7 |
|
|
2021
Q3 | $7.82M | Sell |
13,681
-22
| -0.2% | -$12.1K | 2.45% | 7 |
|
|
2021
Q2 | $6.91M | Sell |
13,703
-270
| -2% | -$127K | 2.22% | 9 |
|
|
2021
Q1 | $6.38M | Sell |
13,973
-1,291
| -8% | -$616K | 2.19% | 10 |
|
|
2020
Q4 | $7.11M | Sell |
15,264
-1,103
| -7% | -$517K | 2.56% | 7 |
|
|
2020
Q3 | $7.23M | Sell |
16,367
-572
| -3% | -$236K | 2.97% | 7 |
|
|
2020
Q2 | $6.14M | Sell |
16,939
-992
| -6% | -$333K | 2.88% | 7 |
|
|
2020
Q1 | $5.08M | Sell |
17,931
-463
| -3% | -$146K | 2.75% | 9 |
|
|
2019
Q4 | $5.98M | Sell |
18,394
-2,798
| -13% | -$848K | 2.67% | 7 |
|
|
2019
Q3 | $6.17M | Sell |
21,192
-598
| -3% | -$171K | 2.92% | 4 |
|
|
2019
Q2 | $6.4M | Buy |
21,790
+298
| +1% | +$82.1K | 3.16% | 4 |
|
|
2019
Q1 | $5.88M | Sell |
21,492
-393
| -2% | -$97.8K | 3.06% | 4 |
|
|
2018
Q4 | $4.9M | Sell |
21,885
-1,007
| -4% | -$236K | 3.07% | 4 |
|
|
2018
Q3 | $5.59M | Sell |
22,892
-1,247
| -5% | -$287K | 2.83% | 3 |
|
|
2018
Q2 | $5M | Sell |
24,139
-1,329
| -5% | -$282K | 2.69% | 3 |
|
|
2018
Q1 | $5.26M | Buy |
25,468
+1,959
| +8% | +$411K | 2.86% | 3 |
|
|
2017
Q4 | $4.46M | Buy |
23,509
+839
| +4% | +$161K | 2.45% | 4 |
|
|
2017
Q3 | $4.29M | Buy |
22,670
+608
| +3% | +$110K | 2.52% | 8 |
|
|
2017
Q2 | $3.85M | Sell |
22,062
-976
| -4% | -$164K | 2.53% | 7 |
|
|
2017
Q1 | $3.54M | Sell |
23,038
-1,739
| -7% | -$266K | 2.36% | 10 |
|
|
2016
Q4 | $3.5M | Buy |
24,777
+2,223
| +10% | +$328K | 2.5% | 9 |
|
|
2016
Q3 | $3.59M | Buy |
22,554
+2,024
| +10% | +$312K | 2.66% | 8 |
|
|
2016
Q2 | $3.03M | Buy |
20,530
+3,880
| +23% | +$573K | 2.49% | 16 |
|
|
2016
Q1 | $2.36M | Sell |
16,650
-574
| -3% | -$76.9K | 1.99% | 16 |
|
|
2015
Q4 | $2.44M | Sell |
17,224
-130
| -0.7% | -$17.3K | 2.04% | 17 |
|
|
2015
Q3 | $2.12M | Buy |
17,354
+314
| +2% | +$40.9K | 1.83% | 20 |
|
|
2015
Q2 | $2.21M | Buy |
17,040
+17
| +0.1% | +$2.22K | 1.76% | 21 |
|
|
2015
Q1 | $2.29M | Buy |
17,023
+403
| +2% | +$52K | 1.85% | 18 |
|
|
2014
Q4 | $2.08M | Sell |
16,620
-1,044
| -6% | -$127K | 1.78% | 21 |
|
|
2014
Q3 | $2.15M | Buy |
17,664
+1,989
| +13% | +$242K | 1.75% | 22 |
|
|
2014
Q2 | $1.85M | Sell |
15,675
-2,545
| -14% | -$300K | 1.56% | 23 |
|
|
2014
Q1 | $2.19M | Sell |
18,220
-12,750
| -41% | -$1.52M | 2.04% | 19 |
|
|
2013
Q4 | $3.45M | Sell |
30,970
-912
| -3% | -$90.7K | 3.29% | 6 |
|
|
2013
Q3 | $2.94M | Sell |
31,882
-4,417
| -12% | -$399K | 3.04% | 5 |
|
|
2013
Q2 | $3.07M | Buy |
+36,299
| New | +$3.02M | 3.02% | 4 |
|
Other funds holding TMO
VCM
Westover Capital Advisors's TMO Position: Q1 2026 in Review
Westover Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 2.8% in Q1 2026, selling an estimated $90.1K and leaving 5,727 shares worth $2.82M. The position accounts for 0.52% of the portfolio, ranked #45.
Westover Capital Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.25M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Westover Capital Advisors held 5,727 shares of Thermo Fisher Scientific worth $2.82M as of Q1 2026.
- Westover Capital Advisors sold 166 Thermo Fisher Scientific shares in Q1 2026, an estimated $90.1K.
- Thermo Fisher Scientific made up 0.52% of Westover Capital Advisors's portfolio in Q1 2026, its #45 holding.
- Westover Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Westover Capital Advisors's Thermo Fisher Scientific position peaked at $8.25M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Westover Capital Advisors's 13F filing for Q1 2026, filed 5 May 2026.